Adherence evaluation of osteoporosis treatment FRESH-PEF151-en Christel LECLERC-ZWIRN Adherence evaluation of osteoporosis treatment ADEOS FRESH-PEF151-en 151 FRESH-PEF151 Christel LECLERC-ZWIRN GLAXOSMITHKLINE (FRANCE) Epidemiology France Portal (PEF) GLAXOSMITHKLINE (FRANCE) null Christel;LECLERC-ZWIRN adhesion tool osteoporosis observance persistence Gynaecology and obstetrics Rheumatology Osteoporosis Healthcare system determinants: Use of care Healthcare system determinants Finalize and validate a self-administered instrument developed to evaluate adhesion to the treatment of postmenopausal osteoporosis null France Individuals Patients population Female Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Woman; Over the age of 50 years; Patient to whom has been prescribed one of the following osteoporosis treatments in the six months prior to the inclusion starting date: bisphosphonates, selective estrogen receptor modulators (SERM), or strontium ranelate; Patient fluent in French and who has the cognitive and functional ability required to complete the self-questionnaires included in the study on their own; Informed patient who has given their oral consent to participate in this study Clinical data Participant-reported health data Others One-time cross-sectional study Other Through independent healthcare practitioners < 500 individuals Self-administered questionnaire Observational Study Observational Study 350 Completed study Restricted access Access on specific project only